|
|
Sesen Bio Inc
SESN's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Sesen Bio Inc 's sales fell
in III. Quarter 2022 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -3.56 %
Sesen Bio Inc realized net income compared to net loss a year ago in III. Quarter 2022
• More on SESN's Growth
|
|
Sesen Bio Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Sesen Bio Inc PEG ratio is at -0.02
|
| Company |
| |
|
PE TTM
|
| Industry |
|
0.01 |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.64.
• More on SESN's Valuation
|
|
|
|
|
Sesen Bio Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Sesen Bio Inc PEG ratio is at -0.02
|
| Company |
| |
|
PE TTM
|
| Industry |
|
0.01 |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.64.
| | | |
